Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;13(8):e006967.
doi: 10.1161/CIRCOUTCOMES.120.006967. Epub 2020 Jun 17.

American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines

Heather M Alger  1 , Christine Rutan  1 , Joseph H Williams 4th  1 , Jason G Walchok  1 , Michele Bolles  1 , Jennifer L Hall  1   2 , Steven M Bradley  3 , Mitchell S V Elkind  4   5 , Fatima Rodriguez  6 , Tracy Y Wang  7 , David A Morrow  8 , Sandeep R Das  9 , James A de Lemos  9
Affiliations
Review

American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines

Heather M Alger et al. Circ Cardiovasc Qual Outcomes. 2020 Aug.

Abstract

Background: In response to the public health emergency created by the coronavirus disease 2019 (COVID-19) pandemic, American Heart Association volunteers and staff aimed to rapidly develop and launch a resource for the medical and research community to expedite scientific advancement through shared learning, quality improvement, and research. In <4 weeks after it was first announced on April 3, 2020, AHA's COVID-19 CVD Registry powered by Get With The Guidelines received its first clinical records.

Methods and results: Participating hospitals are enrolling consecutive hospitalized patients with active COVID-19 disease, regardless of CVD status. This hospital quality improvement program will allow participating hospitals and health systems to evaluate patient-level data including mortality rates, intensive care unit bed days, and ventilator days from individual review of electronic medical records of sequential adult patients with active COVID-19 infection. Participating sites can leverage these data for onsite, rapid quality improvement, and benchmarking versus other institutions. After 9 weeks, >130 sites have enrolled in the program and >4000 records have been abstracted in the national dataset. Additionally, the aggregate dataset will be a valuable data resource for the medical research community.

Conclusions: The AHA COVID-19 CVD Registry will support greater understanding of the impact of COVID-19 on cardiovascular disease and will inform best practices for evaluation and management of patients with COVID-19.

Keywords: benchmarking; cardiovascular diseases; intensive care unit; quality improvement; registries.

PubMed Disclaimer

Figures

Figure:
Figure:
Abbreviated timeline of development for AHA’s COVID-19 CVD Registry Powered by Get With The Guidelines®. Following the first known reports of the novel coronavirus globally, and within the United States, the American Heart Association COVID-19 CVD Registry Quality Improvement program and platform was conceptualized. Four weeks after the Registry was announced, the first records were uploaded into the platform. An aggregated, deidentified aggregate dataset will be available for investigator-initiated analyses.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A and Uriel N. COVID-19 and Cardiovascular Disease. Circulation. 2020;141:1648–1655. - PubMed
    1. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M and Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;323:1612–1614. - PMC - PubMed
    1. Ruan Q, Yang K, Wang W, Jiang L and Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020;46:846–848. - PMC - PubMed
    1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X and Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. DOI: 10.1001/jamacardio.2020.1017. - DOI - PMC - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H and Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet(London, England). 2020;395:1054–1062. - PMC - PubMed

Publication types